CTLA4 and glioblastoma: Despite its success in other malignancies, the ICI inhibition of programmed cell death receptor-1 (PD-1)/programmed death ligand-1 (PD-L1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) has failed miserably in GBM so far [3].